Delay aversion: Effects of 7-OH-DPAT, 5-HT1A/1B-receptor stimulation and d-cycloserine

Pharmacology Biochemistry and Behavior

Volumn 85, Issue 4, 2006, Pages 736-743

  van den Bergh, Filip S ^a   Bloemarts, Emilie ^a   Groenink, Lucianne ^a   Olivier, Berend ^a   Oosting, Ronald S ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Dopamine; Glutamate; Impulsivity; Operant conditioning; Serotinin

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; CYCLOSERINE; DEXAMPHETAMINE; DOPAMINE 3 RECEPTOR BLOCKING AGENT; ELTOPRAZINE; FLESINOXAN; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; SEROTONIN 1A AGONIST; SEROTONIN 1B AGONIST; SEROTONIN 1B ANTAGONIST;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVERSION; CONTROLLED STUDY; DRUG DOSE COMPARISON; IMPULSIVENESS; INSTRUMENTAL CONDITIONING; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CYCLOSERINE; DEXTROAMPHETAMINE; IMPULSIVE BEHAVIOR; MALE; OXADIAZOLES; PIPERAZINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, DOPAMINE D3; RECEPTORS, N-METHYL-D-ASPARTATE; TETRAHYDRONAPHTHALENES;

ANIMALIA; RATTUS;

EID: 33846526183     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.11.007     Document Type: Article

References (70)

1. Acosta J.I., Boynton F.A., Kirschner K.F., and Neisewander J.L. Stimulation of 5-HT1B receptors decreases cocaine- and sucrose-seeking behavior. Pharmacol Biochem Behav 80 (2005) 297-307
2. Ainslie G. Specious reward: a behavioral theory of impulsiveness and impulse control. Psychol Bull 82 (1975) 463-496
3. Alessi S.M., and Petry N.M. Pathological gambling severity is associated with impulsivity in a delay discounting procedure. Behav Processes 64 (2003) 345-354
4. Andreoli M., Tessari M., Pilla M., Valerio E., Hagan J.J., and Heidbreder C.A. Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology 28 (2003) 1272-1280
5. Arnsten A.F. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology 31 11 (2006) 2376-2383
6. Ashby Jr. C.R., Paul M., Gardner E.L., Heidbreder C.A., and Hagan J.J. Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats. Synapse 48 (2003) 154-156
7. Barkley R.A. Response inhibition in attention-deficit hyperactivity disorder. Ment Retard Dev Disabil 5 (1999) 177-184
8. Beninger R.J., and Phillips A.G. Possible involvement of serotonin in extinction. Pharmacol Biochem Behav 10 (1979) 37-41
9. Bickel W.K., Odum A.L., and Madden G.J. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl) 146 (1999) 447-454
10. Bouthenet M.L., Souil E., Martres M.P., Sokoloff P., Giros B., and Schwartz J.C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564 (1991) 203-219
11. Cardinal R.N., Robbins T.W., and Everitt B.J. The effects of d-amphetamine, chlordiazepoxide, alpha-flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in rats. Psychopharmacology (Berl) 152 (2000) 362-375
12. Cardinal R.N., Daw N., Robbins T.W., and Everitt B.J. Local analysis of behaviour in the adjusting-delay task for assessing choice of delayed reinforcement. Neural Netw 15 (2002) 617-634
13. Charrier D., and Thiebot M.H. Effects of psychotropic drugs on rat responding in an operant paradigm involving choice between delayed reinforcers. Pharmacol Biochem Behav 54 1 (1996) 149-157
14. Coffey S.F., Gudleski G.D., Saladin M.E., and Brady K.T. Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Exp Clin Psychopharmacol 11 (2003) 18-25
15. Dalen L., Sonuga-Barke E.J., Hall M., and Remington B. Inhibitory deficits, delay aversion and preschool AD/HD: implications for the dual pathway model. Neural Plast 11 (2004) 1-11
16. Damsma G., Bottema T., Westerink B.H., Tepper P.G., Dijkstra D., Pugsley T.A., et al. Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand. Eur J Pharmacol 249 (1993) R9-R10
17. De Boer S.F., and Koolhaas J.M. 5-HT(1A) and 5-HT(1B) receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. Eur J Pharmacol 526 (2005) 125-139
18. De Boer S.F., Lesourd M., Mocaer E., and Koolhaas J.M. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: a comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635. J Pharmacol Exp Ther 288 (1999) 1125-1133
19. De Groote L., Olivier B., and Westenberg H.G. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice. Psychopharmacology (Berl) 162 (2002) 419-424
20. DSM-IV. Diagnostic and statistical manual of mental disorders. Text Revision. 4th ed. (2000), American Psychiatric Association
21. Evenden J.L. Varieties of impulsivity. Psychopharmacology (Berl) 146 (1999) 348-361
22. Evenden J.L., and Ryan C.N. The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl) 128 (1996) 161-170
23. Evenden J.L., and Ryan C.N. The pharmacology of impulsive behaviour in rats VI: the effects of ethanol and selective serotonergic drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl) 146 (1999) 413-421
24. Falls W.A., Miserendino M.J., and Davis M. Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci 12 (1992) 854-863
25. Fuchs R.A., Tran-Nguyen L.T., Weber S.M., Khroyan T.V., and Neisewander J.L. Effects of 7-OH-DPAT on cocaine-seeking behavior and on re-establishment of cocaine self-administration. Pharmacol Biochem Behav 72 3 (2002) 623-632
26. Gilbert J.G., Newman A.H., Gardner E.L., Ashby Jr. C.R., Heidbreder C.A., Pak A.C., et al. Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors. Synapse 57 (2005) 17-28
27. Heidbreder C.A., Andreoli M., Marcon C., Thanos P.K., Ashby Jr. C.R., and Gardner E.L. Role of dopamine D3 receptors in the addictive properties of ethanol. Drugs Today (Barc) 40 (2004) 355-365
28. Heidbreder C.A., Gardner E.L., Xi Z.X., Thanos P.K., Mugnaini M., Hagan J.J., et al. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev 49 (2005) 77-105
29. Kirby K.N., Petry N.M., and Bickel W.K. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 128 (1999) 78-87
30. Ledgerwood L., Richardson R., and Cranney J. d-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction. Biol Psychiatry 57 (2005) 841-847
31. Liu Y.P., Wilkinson L.S., and Robbins T.W. Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex. Psychopharmacology (Berl) 173 (2004) 175-185
32. Logue A.W., Tobin H., Chelonis J.J., Wang R.Y., Geary N., and Schachter S. Cocaine decreases self-control in rats: a preliminary report. Psychopharmacology (Berl) 109 1-2 (1992) 245-247
33. Mazur J.E. Estimation of indifference points with an adjusting-delay procedure. J Exp Anal Behav 49 (1988) 37-47
34. Mazur J.E., and Coe D. Tests of transitivity in choices between fixed and variable reinforcer delays. J Exp Anal Behav 47 3 (1987) 287-297
35. Mitchell J.M., Fields H.L., D'Esposito M., and Boettiger C.A. Impulsive responding in alcoholics. Alcohol Clin Exp Res 29 (2005) 2158-2169
36. Myerson J., Green L., and Warusawitharana M. Area under the curve as a measure of discounting. J Exp Anal Behav 76 (2001) 235-243
37. Ohmura Y., Takahashi T., and Kitamura N. Discounting delayed and probabilistic monetary gains and losses by smokers of cigarettes. Psychopharmacology (Berl) 182 (2005) 508-515
38. Olivier B., Mos J., Raghoebar M., de Koning P., and Mak M. Serenics. Prog Drug Res 42 (1994) 167-308
39. Olivier B., Mos J., van Oorschot R., and Hen R. Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry 28 Suppl 2 (1995) 80-90
40. Olivier B., and van Oorschot R. 5-HT(1B) receptors and aggression: a review. Eur J Pharmacol 526 (2005) 207-217
41. Perry J.L., Larson E.B., German J.P., Madden G.J., and Carroll M.E. Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats. Psychopharmacology (Berl) (2004)
42. Petry N.M. Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls. Psychopharmacology (Berl) 154 (2001) 243-250
43. Petry N.M. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. J Abnorm Psychol 110 (2001) 482-487
44. Port R.L., and Seybold K.S. Manipulation of NMDA-receptor activity alters extinction of an instrumental response in rats. Physiol Behav 64 (1998) 391-393
45. Ratey J.J., and Gordon A. The psychopharmacology of aggression: toward a new day. Psychopharmacol Bull 29 (1993) 65-73
46. Ressler K.J., Rothbaum B.O., Tannenbaum L., Anderson P., Graap K., Zimand E., et al. Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61 (2004) 1136-1144
47. Retz W., Rosler M., Supprian T., Retz-Junginger P., and Thome J. Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology. J Neural Transm 110 (2003) 561-572
48. Reynolds B., Richards J.B., Horn K., and Karraker K. Delay discounting and probability discounting as related to cigarette smoking status in adults. Behav Processes 65 (2004) 35-42
49. Richards J.B., Mitchell S.H., de Wit H., and Seiden L.S. Determination of discount functions in rats with an adjusting-amount procedure. J Exp Anal Behav 67 3 (1997) 353-366
50. Richards J.B., Sabol K.E., and de Wit H. Effects of methamphetamine on the adjusting amount procedure, a model of impulsive behavior in rats. Psychopharmacology (Berl) 146 4 (1999) 432-439
51. Richardson R., Ledgerwood L., and Cranney J. Facilitation of fear extinction by d-cycloserine: theoretical and clinical implications. Learn Mem 11 (2004) 510-516
52. Ridray S., Griffon N., Mignon V., Souil E., Carboni S., Diaz J., et al. Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions. Eur J Neurosci 10 (1998) 1676-1686
53. Rogoz Z., Skuza G., and Kllodzinska A. Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist, in rats. Pol J Pharmacol 56 (2004) 519-526
54. Sagvolden T., Aase H., Zeiner P., and Berger D. Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder. Behav Brain Res 94 (1998) 61-71
55. Schwartz J.C., Diaz J., Bordet R., Griffon N., Perachon S., Pilon C., et al. Functional implications of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence. Brain Res Brain Res Rev 26 (1998) 236-242
56. Sokoloff P., Andrieux M., Besancon R., Pilon C., Martres M.P., Giros B., et al. Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur J Pharmacol 225 (1992) 331-337
57. Sokoloff P., Giros B., Martres M.P., Andrieux M., Besancon R., Pilon C., et al. Localization and function of the D3 dopamine receptor. Arzneimittelforschung 42 (1992) 224-230
58. Solanto M.V., Abikoff H., Sonuga-Barke E., Schachar R., Logan G.D., Wigal T., et al. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD. J Abnorm Child Psychol 29 (2001) 215-228
59. Sonuga-Barke E.J. Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry 57 (2005) 1231-1238
60. Sonuga-Barke E.J., Dalen L., and Remington B. Do executive deficits and delay aversion make independent contributions to preschool attention-deficit/hyperactivity disorder symptoms?. J Am Acad Child Adolesc Psychiatry 42 (2003) 1335-1342
61. Talpos J.C., Wilkinson L.S., and Robbins T.W. A comparison of multiple 5-HT receptors in two tasks measuring impulsivity. J Psychopharmacol 20 1 (2006) 47-58
62. Thanos P.K., Katana J.M., Ashby Jr. C.R., Michaelides M., Gardner E.L., Heidbreder C.A., et al. The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats. Pharmacol Biochem Behav 81 (2005) 190-197
63. Van den Bergh F.S., Spronk M., Ferreira L., Bloemarts E., Groenink L., Kenemans J.L., et al. Relationship of delay aversion and response inhibition to extinction learning, aggression, and sexual behaviour. Behav Brain Res 175 1 (2006) 75-81
64. Van Gaalen M.M., van Koten R., Schoffelmeer A.N., and Vanderschuren L.J. Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry 60 (2006) 66-73
65. Wade T.R., de Wit H., and Richards J.B. Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats. Psychopharmacology (Berl). 150 1 (2000) 90-101
66. Walker D.L., Ressler K.J., Lu K.T., and Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 22 (2002) 2343-2351
67. Winstanley C.A., Dalley J.W., Theobald D.E., and Robbins T.W. Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats. Psychopharmacology (Berl) 170 (2003) 320-331
68. Winstanley C.A., Theobald D.E., Dalley J.W., and Robbins T.W. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology 30 (2005) 669-682
69. Xi Z.X., Gilbert J., Campos A.C., Kline N., Ashby Jr. C.R., Hagan J.J., et al. Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats. Psychopharmacology (Berl) 176 (2004) 57-65
70. Xi Z.X., Gilbert J.G., Pak A.C., Ashby Jr. C.R., Heidbreder C.A., and Gardner E.L. Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats. Eur J Neurosci 21 (2005) 3427-3438